Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07461662 · ClinicalTrials.gov registry record · NA

Evaluation of Endobronchial Ultrasound Needle Cleaning Techniques and Their Impact on Specimen Contamination

A NA study, sponsored by University of Mississippi Medical Center.

Not yet
Registry status
NA
Development phase
204
Enrollment target

NCT07461662: Clinical Trial NA study, sponsored by University of Mississippi Medical Center.

NCT07461662 is a NA study that has not yet begun recruiting, run by University of Mississippi Medical Center. The registered enrollment target is 204 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07461662, a NA study, has not yet begun recruiting, sponsored by University of Mississippi Medical Center.

NOT YET RECRUITING
Registry status
NA
Development phase
204 participants
Enrollment target

Study Summary

Endobronchial ultrasound (EBUS) bronchoscopy is commonly used to sample lymph nodes in patients with suspected or known lung cancer to determine the stage of the disease. Accurate staging is essential as it directly impacts treatment decisions and prognosis. During EBUS procedures, needles are often reused across multiple lymph node stations and are typically flushed with saline between samples. This raises the concern that residual tumor cells may contaminate the samples and could potentially incorrectly upstage disease. This prospective study will evaluate the current technique used during EBUS procedures to determine if more intensive cleaning leads to reduced cellular contamination without affecting diagnostics. Patients undergoing an EBUS procedure for diagnosis with a large mass and a high probability of malignancy will be selected for the study. Rapid On-Site Examination (ROSE) will be used at the bedside to determine the presence of abnormal cells. Following the final pass, before moving to the next station, the needle will be flushed with saline as normal and then flushed again into another container to evaluate the presence of residual cells. The outcome may help EBUS needle handling practices and improve lung cancer staging accuracy. No additional invasive procedures are performed as part of this study; all analyses utilize material obtained during routine EBUS needle flushing, with no added needle sticks or alteration of clinical care.

Primary Outcome

To determine the presence of cytologic contamination following standard practice cleaning techniques

Interventions

  • DIAGNOSTIC_TEST Purge cleaning

Trial Details

FieldValue
Enrollment Target 204 participants
Start Date 2026-04-01
Est. Completion 2027-08-31
Phase NA

What is known before NCT07461662 opens enrollment

NCT07461662 is an interventional study that assigns participants to a tested intervention. The registered 204 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).

The record links to 0 conditions, and to 1 intervention - of which Purge cleaning is the first listed.

NCT07461662 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07461662 about?

NCT07461662 is a clinical study titled "Evaluation of Endobronchial Ultrasound Needle Cleaning Techniques and Their Impact on Specimen Contamination". Endobronchial ultrasound (EBUS) bronchoscopy is commonly used to sample lymph nodes in patients with suspected or known lung cancer to determine the stage of the disease. Accurate staging is essential as it directly impacts treatment decisions and prognosis. During EBUS procedures, needles are often...

What is the current status of trial NCT07461662?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 204 participants. The study started on 2026-04-01. Estimated completion is 2027-08-31.

What interventions are being tested in trial NCT07461662?

The interventions under investigation include: Purge cleaning (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT07461662?

This trial is sponsored by University of Mississippi Medical Center, which has 96 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07461662's enrollment target sits among peer trials

204 500th of 2000 higher than 1,497 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03481010 · 204 participants · NA

    Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology

  • NCT04249830 · 204 participants · NA

    Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults

  • NCT04503395 · 204 participants · NA

    ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES

  • NCT04793776 · 204 participants · NA

    Manage Emotions to Reduce Aggression (MERA)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07461662, the US trial registry maintained by the National Library of Medicine. NCT07461662 (mid enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.